HARMONY HOPKINS: Open Payments
NPI 1922522895 · AGAWAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,097 in 254 payments from 23 companies in 2025. Trend: 2023 $3,919 · 2024 $4,361 · 2025 $5,097
Food & beverage: $4,822Education: $276
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $875 |
| UCB, Inc. | 33 | $617 |
| Janssen Biotech, Inc. | 23 | $530 |
| Novartis Pharmaceuticals Corporation | 19 | $426 |
| Arcutis Biotherapeutics, Inc. | 20 | $330 |
| GENZYME CORPORATION | 8 | $303 |
| Incyte Corporation | 15 | $296 |
| Lilly USA, LLC | 14 | $285 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $283 |
| Galderma Laboratories, L.P. | 15 | $227 |
Products named: Bimzelx, TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, Zoryve, OPZELURA, COSENTYX.
Industry payments across MA — which companies pay providers there.
